Clinical Trial Update: Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Cenegermin (Oxervate) versus vehicle for severe Sjogren's dry eye disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Sjogren Syndrome

Drugs mentioned

• Oxervate (cenegermin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-12-04